Cargando…

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer

Immunotherapy has made significant advances in the treatment of colorectal cancer (CRC), revolutionizing the therapeutic landscape and highlighting the indispensable role of the tumor immune microenvironment. However, some CRCs have shown poor response to immunotherapy, prompting investigation into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Shiya, Han, Yuejun, Yang, Mengxiang, Jin, Ketao, Lan, Huanrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619163/ https://www.ncbi.nlm.nih.gov/pubmed/37920463 http://dx.doi.org/10.3389/fimmu.2023.1241208

Ejemplares similares

From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?
por: Yao, Shiya, et al.
Publicado: (2023)

Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
por: He, Xing, et al.
Publicado: (2023)

Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors
por: Chen, Min, et al.
Publicado: (2023)

Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review
por: Fang, Xingliang, et al.
Publicado: (2022)

Cholesterol in colorectal cancer: an essential but tumorigenic precursor?
por: He, Xing, et al.
Publicado: (2023)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective
por: Lan, Huanrong, et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
por: Bai, Ziyi, et al.
Publicado: (2022)

Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase
por: Huang, Liming, et al.
Publicado: (2019)

Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
por: Ngiow, Shin Foong, et al.
Publicado: (2020)

Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy
por: Huang, Xi, et al.
Publicado: (2023)

Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022)

Colorectal Cancer Immunotherapy: Options and Strategies
por: Johdi, Nor Adzimah, et al.
Publicado: (2020)

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
por: Berckmans, Yani, et al.
Publicado: (2023)

Antitumor effect of FP3 in a breast cancer xenograft model
por: LAN, HUANRONG, et al.
Publicado: (2013)

Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives
por: Chen, Min, et al.
Publicado: (2023)

Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment
por: Fang, Xingliang, et al.
Publicado: (2023)

“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
por: Liu, Kevin X., et al.
Publicado: (2020)

Complement System: An Immunotherapy Target in Colorectal Cancer
por: Talaat, Iman M., et al.
Publicado: (2022)

Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
por: Kouakanou, Léonce, et al.
Publicado: (2021)

The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma
por: Ye, Ting, et al.
Publicado: (2022)

CAR T-cells for colorectal cancer immunotherapy: Ready to go?
por: Ghazi, Bouchra, et al.
Publicado: (2022)

A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model
por: Guan, Zhonghai, et al.
Publicado: (2019)

Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer
por: Huang, Xingxing, et al.
Publicado: (2022)

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching
por: Jing, Shao-Wu, et al.
Publicado: (2022)

Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
por: Ghiringhelli, François, et al.
Publicado: (2019)

Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
por: Hou, Xinxin, et al.
Publicado: (2022)

Immunotherapies catering to the unmet medical need of cold colorectal cancer
por: Yuan, Jun, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023)

Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer
por: Lin, Guang-Tan, et al.
Publicado: (2022)

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2020)

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?
por: Farag, Kristine I., et al.
Publicado: (2021)

ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022)

Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution – A role for immunotherapy
por: Tieng, Francis Yew Fu, et al.
Publicado: (2022)

Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
por: Bascuas, Thais, et al.
Publicado: (2018)

Effects of chemotherapy and immunotherapy on microbial diversity in TME and engineered bacterial-mediated tumor therapy
por: Zheng, Heng, et al.
Publicado: (2023)

SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
por: Xu, Houshi, et al.
Publicado: (2022)

T Cell Epitope Prediction and Its Application to Immunotherapy
por: Schaap-Johansen, Anna-Lisa, et al.
Publicado: (2021)

Editorial: Translational phenomics and its applications in immunotherapy
por: Fang, Hai, et al.
Publicado: (2023)

Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
por: Picard, Emilie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_54gg26c8rqea7433tc5123l6pb